News
10-12-2010, 10:21 PM
US Oncology, Inc., the nation's leading integrated oncology company, announced today that it has enrolled the 1,000th patient in a Phase I clinical trial through its US Oncology Research Network. Phase I clinical trials present special challenges, including increased safety concerns, higher variability of patient disease, more complex trial designs, and some first-in-human trials, making Phase I trials more difficult to operate in the community setting.
More... (http://www.news-medical.net/news/20101013/US-Oncology-enrolls-1000th-patient-in-Phase-I-clinical-trial.aspx)
More... (http://www.news-medical.net/news/20101013/US-Oncology-enrolls-1000th-patient-in-Phase-I-clinical-trial.aspx)